Fluidigm raises another $7.5M for stem-cell analysis chips
Fluidigm, which makes chips that for genetics lab, has raised $7.5 million in new equity, according to VentureWire. That’s part of a new $18.5 million round that the South San Francisco, Calif. company is raising. The funding comes from existing backers Alloy Ventures, EDB Investments, EuclidSR partners, Fidelity Contrafund, Interwest Partners, Lehman Brothers Venture Capital Group, Smallcap World Fund, and Versant Ventures, as well as an undisclosed new investor.
Fluidigm tried to have an IPO a year ago but pulled it due to the weak market.
Next Story: Seesmic jumps on Twitter's new location feature with map previews
Previous Story: Politics and policy needed for the smart grid. Soon.
About the Author, Anthony Ha
Anthony is a senior editor at VentureBeat, as well as its reporter on media, advertising, and social networks. Before joining the site in 2008, Anthony worked at the Hollister Free Lance, where he won awards from the California Newspaper Publishers Association for breaking news coverage and writing. He attended Stanford University and now lives in San Francisco. Reach him at anthony@venturebeat.com. (All story pitches should also be sent to tips@venturebeat.com) You can also follow Anthony on Twitter.
